Engage Virtual Protection is a company that specializes in providing virtual protection services, which likely includes cybersecurity solutions, risk management, and digital threat mitigation for businesses and individuals.

Engage Virtual Protection

We are a team of investors and entrepreneurs who are passionate about medtech innovation.

We’re not a traditional VC fund. When we back a portfolio company, we amplify our own capital by inviting our Investor Network to co-invest alongside us in a dedicated Special Purpose Vehicle (SPV).

As an Engage Investor Network member, you get access to our proprietary early-stage deal flow, supported by our expert research and due diligence. You have the flexibility to choose which companies to support — with low investment minimums, no subscription fees, and no annual commitments.

To learn how you can join us in powering medtech innovation, please email: investors@engagevp.com.

Engage Venture Partners

Excited to report that our portfolio company Pleural Dynamics, Inc. just received 510(k) clearance from the FDA for their flagship Automatic Continuous Effusion Shunt (ACES) product. This is a major commercialization milestone that sets the stage for US clinical use. 

Congratulations, Martin Mayse, John Streeter and team!

Thanks to Minneapolis/St. Paul Business Journal (MSPBJ) and Minne Inno for recognizing Engage as a 2023 Blazer Award winner!

Steve Sigmond Morgan Evans Ryan Spanheimer Kelly Prchal, MHA

#medtech #medtechinnovation #venturecapital #investing

Announcing our latest portfolio company!

Laplace Interventional is developing a novel prosthetic valve for treating tricuspid regurgitation (TR), a structural heart disease that impacts quality of life and long-term survival for 4.6 million people in the US and Europe. We believe Laplace’s product has the potential to pioneer a vastly simpler, superior standard of care for treating TR, thereby addressing an enormous unmet clinical and market need.

"Engage participated in our recent Series B financing and I truly consider them to be value-added investors that bring in smart money. Engage's due diligence on complex issues was very thorough. They moved quickly on an aggressive timetable to bring important funding that will enable us to accelerate the development of our novel tricuspid heart valve." - Ramji Iyer, Founder & CEO

To learn how you can support medtech innovation by participating in future Engage investments, please email: investors@engagevp.com.

Happy birthday to Engage! We had a busy first year powering medtech innovation. Amid a challenging early-stage funding environment, our investors backed six game-changing companies, providing $5.5 million in critical growth capital. We are thrilled to see rapid growth in our Investor Network — individuals, family offices, and other institutional investors. We’re just getting started — we look forward to many more years of supporting this important innovation ecosystem together. Please reach out if you’d like to learn more and get involved! investors@engagevp.com 

Morgan Evans, Ryan Spanheimer, Steve Sigmond, Kelly Prchal, MHA

#medtech #earlystageinvesting #medtechinnovation #venturecapital #angelinvesting

We are honored to be recognized as a 2023 Minneapolis/St. Paul Business Journal (MSPBJ) Fire Award winner! Thank you to all our portfolio companies and Engage Investor Network members for helping us power medtech innovation… in Minnesota and beyond.

We're excited to announce our latest portfolio company!
 
Pleural Dynamics is developing two novel implantable devices for the management of chronic, recurrent fluid collections within the body. We believe the company’s innovative, elegant products will offer significant long-term cost savings and quality of life improvements for patients who are often at the end stage of life. We're proud to be supporting Martin Mayse, John Streeter, and their team on this journey!
 
"We greatly valued Engage's participation in our Series A raise. They bring an exceptional level of healthcare and medtech domain expertise and their robust due diligence process and strong network of experienced investors gave us great insights. Engage and their investors are helping us fund preparations for the commercial launch of our first two products.” - Martin Mayse, CEO
 
To learn how you can support medtech innovation by participating in future Engage investment opportunities, please email: investors@engagevp.com.
 
#medtech #venturecapital #investment #healthcare #innovation

Our own Morgan Evans spent the better part of an hour with Holly Knoll talking about her experience as a medtech entrepreneur and venture capitalist. Thanks for sharing your experiences with us Morgan!

https://lnkd.in/gSxacfYx

#medtech #venturecapital #innovationinhealthcare

We are looking forward to connecting with other thought leaders and keeping a pulse on the angel investing scene here in Minnesota at Angel Fest. Don't miss the 'Talk Numbers to Me' panel in the morning with our very own Kelly Prchal, Founder and Managing Director.

Get your tickets here: https://lnkd.in/gXFZw8dB
and let us know below if you plan to be there! 

#angelinvesting #healthcareinnovation #venturecapital

Are you interested in supporting medtech innovation? Then talk to us about joining the Engage Investor Network!

You’ll have the opportunity to co-invest with us in private companies that pass our rigorous due diligence process. You get to choose which deals to participate in. We put our money where our mouth is — we personally invest in every company that we show to investors.

There’s no cost to join, no subscription fees, and no annual commitments. If you’re an accredited investor and want to tap into our medtech deal flow, please email: investors@engagevp.com.

COM:ENGAGEVP

Engage Virtual Protection

People Not Available